SCHEMBL7215427

SCHEMBL7215427

COC(=O)c1ccc(-c2nc(-c3cccc(Cl)c3)cs2)cc1

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.56
ABL1 P00519 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.53
NPC1 O15118 6/20 0.53
RAB9A P51151 6/20 0.53
KDM4E B2RXH2 6/20 0.53
SMN1; SMN2 Q16637 5/20 0.53
MEN1 O00255 3/20 0.53
KMT2A Q03164 3/20 0.53
MAPT P10636 1/20 0.53
CYP1A1 P04798 1/20 0.52
CYP1A2 P05177 1/20 0.52
CYP1B1 Q16678 1/20 0.52
ALDH1A1 P00352 2/20 0.51
CRHBP P24387 1/20 0.50
CRHR2 Q13324 1/20 0.50
EIF4E P06730 1/20 0.49
GSTO1 P78417 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7217216 0.86 RAB9A (0.71) CYP19A1ABL1NPC1RAB9AKDM4E
SCHEMBL7215184 0.85 KDM4E (0.73) CYP19A1ABL1NPC1RAB9AKDM4E
SCHEMBL1198971 0.84 ABL1 (0.51) CYP19A1ABL1L3MBTL1KDM4ESMN1; SMN2
SCHEMBL1505401 0.82 SMN1; SMN2 (0.53) NPC1RAB9AKDM4ESMN1; SMN2MEN1
SCHEMBL7221542 0.82 ALDH1A1 (0.55) CYP19A1NPC1RAB9AKDM4ESMN1; SMN2
SCHEMBL7221993 0.81 KDM4E (0.53) L3MBTL1NPC1RAB9AKDM4ESMN1; SMN2
SCHEMBL7220984 0.80 RAB9A (0.55) NPC1RAB9AKDM4ESMN1; SMN2MEN1
SCHEMBL7215145 0.80 MAPT (0.61) NPC1RAB9AKDM4ESMN1; SMN2MEN1
Bromide SCHEMBL7215296 0.80 CYP19A1 (0.67) CYP19A1L3MBTL1NPC1RAB9AKDM4E
SCHEMBL28526442 0.79 SREBF2 (0.68) CYP19A1ABL1L3MBTL1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6545009-B1 Imidazole, oxazole and thiazole derivatives for regulation of peroxisome proliferator-activated receptor function; improving insulin resistance, treating impaired glucose tolerance and obesity, enhancing insulin sensitivity, etc. TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2003-04-08 US disclosed
CN-1314899-A Retinoid-associated receptor regulators TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2001-09-26 CN disclosed
EP-1092711-A1 RETINOID-ASSOCIATED RECEPTOR REGULATORS Takeda Chemical Industries, Ltd. (JP) 2001-04-18 EP disclosed